In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clordiazepoxido Drug Master File in Korea (Clordiazepoxido KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clordiazepoxido. The MFDS reviews the Clordiazepoxido KDMF as part of the drug registration process and uses the information provided in the Clordiazepoxido KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clordiazepoxido KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clordiazepoxido API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clordiazepoxido suppliers with KDMF on PharmaCompass.